| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 932,800 | 778,000 | 918,000 | 1,782,400 | | Cost of Revenue | 922,500 | 720,200 | 816,600 | 2,656,700 | | | Gross Profit | 10,300 | 57,800 | 101,400 | (874,300) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 152,400 | 144,100 | 150,200 | 202,000 | | Non Recurring |
-
|
-
|
-
| 79,400 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (142,100) | (86,300) | (48,800) | (1,155,700) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 600 | 6,700 | 13,800 | 7,600 | | Earnings Before Interest And Taxes | (141,500) | (79,600) | (35,000) | (1,148,100) | | Interest Expense | 20,400 | 23,400 | 26,300 | 17,100 | | Income Before Tax | (161,900) | (103,000) | (61,300) | (1,165,200) | | Income Tax Expense | (19,600) | 5,500 | 1,300 | (365,400) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (142,300) | (108,500) | (62,600) | (799,800) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (142,300) | (108,500) | (62,600) | (799,800) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($142,300) | ($108,500) | ($62,600) | ($799,800) |
|
0.26% Nasdaq 
Income Statement
